, Tracking Stock Market Picks
Enter Symbol:

up 1,667.09 %

PHARMASSET INC. (VRUS) rated Buy by Merriman Curhan Ford

Posted on: Tuesday,  Mar 11, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy PHARMASSET INC. (NASDAQ: VRUS) on 03/11/2008, when the stock price was $7.75. Since
then, PHARMASSET INC. has gained 1667.10% as of 01/17/2012's recent price of $136.95.
If you would have followed this Merriman Curhan Ford's recommendation on VRUS, you would have gained 1667.09% of your investment in 1407 days.

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of drugs to treat viral infections. It focuses on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/11/2008 8:25 AM Buy
as of 12/24/2008
1 Week up  0.97 %
1 Month up  4.70 %
3 Months down  -15.09 %
1 YTD down  -28.75 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy